FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

Hearing to Grill FDA Center Directors

The House Energy and Commerce Committee announces a 5/22 hearing titled Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices, which wil...

latest-news-card-1
Medical Devices

FDA OKs Breakthrough Colorectal Cancer Test

FDA approves Geneoscopys colorectal cancer stool-based screening test ColoSense for those aged 45 years and older with an average risk for developing ...

latest-news-card-1
Biologics

Lilly Gets 6/10 Panel Date for Alzheimers BLA

FDA announces a 6/10 Peripheral and Central Nervous System Drugs Advisory Committee meeting to vote on an Eli Lilly BLA for Alzheimers drug donanemab....

latest-news-card-1
Federal Register

Guide on REMS Logic Model

Federal Register notice: FDA makes available a draft guidance entitled REMS Logic Model: A Framework to Link Program Design With Assessment.

latest-news-card-1
Human Drugs

House Committee Pressures FDA on China Oversight

The House Oversight Committee puts pressure on FDA and its oversight of imported Chinese and other foreign active pharmaceutical ingredients and finis...

latest-news-card-1
Human Drugs

Bioresearch Monitoring Violations at DBC Research

FDA warns Dr. Kevin Bender, doing business as DBC Research in Tamarac, FL, about violations in his conduct of clinical trials.

latest-news-card-1
Human Drugs

Endo Paying $1.5 Billion Fines, Forfeitures

Endo is ordered to pay $1.85 billion in fines and forfeitures after pleading guilty to introducing misbranded Opana ER into interstate commerce and cl...

latest-news-card-1
Medical Devices

Multiple Violations in Bioptimal Inspection

FDA warns Chinas Bioptimal International about multiple violations at a Singapore facility manufacturing two unapproved catheters.

latest-news-card-1
Medical Devices

CDRH Product Evaluation/Quality Office Modified

Federal Register notice: FDA announces that CDRH Office of Product Evaluation and Quality has modified its organizational structure.

latest-news-card-1
Human Drugs

FDA OKs TE Code for Paclitaxel Suspension

FDA approves an AB therapeutic equivalence code for cancer drug paclitaxel suspension and tells HBT Labs it must formally apply for a return of PDUFA ...